{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:13:19Z","timestamp":1788135199072,"version":"build-2803163510"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,27]]},"DOI":"10.7759\/cureus.100214","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T23:36:06Z","timestamp":1766878566000},"source":"Crossref","is-referenced-by-count":3,"title":["Rebound Pruritus and Urticaria Post-discontinuation of Chronic Cetirizine Use: A Case Report"],"prefix":"10.7759","author":[{"given":"Jun Jie Benjamin","family":"Seng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prawira","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Cetirizine","author":"Naqvi A","year":"2025","unstructured":"Naqvi A, Patel P, Gerriets V. Cetirizine. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.007211","article-title":"Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu)","volume":"34","author":"Gupta A","year":"2006","unstructured":"Gupta A, Chatelain P, Massingham R, Jonsson EN, Hammarlund-Udenaes M. Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu). Drug Metab Dispos. 2006, 34:318-23. 10.1124\/dmd.105.007211","journal-title":"Drug Metab Dispos"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1939-4551-1-9-145","article-title":"H1 antihistamines: current status and future directions","volume":"1","author":"Simons FE","year":"2008","unstructured":"Simons FE, Simons KJ. H1 antihistamines: current status and future directions. World Allergy Organ J. 2008, 1:145-55. 10.1186\/1939-4551-1-9-145","journal-title":"World Allergy Organ J"},{"key":"ref4","unstructured":"MedHelp. Addicted to Zyrtec?. (2016). Accessed. December 8, 2025: http:\/\/www.medhelp.org\/posts\/Allergy\/addicted-to-zyrtec\/show\/600862."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40800-016-0041-9","article-title":"Unbearable pruritus after withdrawal of (levo)cetirizine","volume":"3","author":"Ekhart C","year":"2016","unstructured":"Ekhart C, van der Horst P, van Hunsel F. Unbearable pruritus after withdrawal of (levo)cetirizine. Drug Saf Case Rep. 2016, 3:16. 10.1007\/s40800-016-0041-9","journal-title":"Drug Saf Case Rep"},{"key":"ref6","unstructured":"FDA requires warning about rare but severe itching after stopping long-term use of oral allergy medicines cetirizine or levocetirizine (Zyrtec, Xyzal, and other trade names). (2025). Accessed. December 15, 2025: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requires-warning-about-rare-severe-itching-after-stopping-...."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2042098619859996","article-title":"Pruritus after discontinuation of cetirizine","volume":"10","author":"Chung AH","year":"2019","unstructured":"Chung AH, La Grenade L, Harinstein LM. Pruritus after discontinuation of cetirizine. Ther Adv Drug Saf. 2019, 10:2042098619859996. 10.1177\/2042098619859996","journal-title":"Ther Adv Drug Saf"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7453\/gahmj.2013.008","article-title":"The CARE guidelines: consensus-based clinical case reporting guideline development","volume":"2","author":"Gagnier JJ","year":"2013","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med. 2013, 2:38-43. 10.7453\/gahmj.2013.008","journal-title":"Glob Adv Health Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/WOX.0b013e3181b35322","article-title":"The role of antihistamines in the treatment of vasomotor rhinitis","volume":"2","author":"Lieberman P","year":"2009","unstructured":"Lieberman P. The role of antihistamines in the treatment of vasomotor rhinitis. World Allergy Organ J. 2009, 2:156-61. 10.1097\/WOX.0b013e3181b35322","journal-title":"World Allergy Organ J"},{"key":"ref11","unstructured":"GlaxoSmithKline. Cetirizine - drug information leaflet. (2023). Accessed. December 15, 2025: https:\/\/assets.gskstatic.com\/pharma\/PM-PI_portal\/Cambodia\/zyrtec_tablet_10mg_pi_km_kh.pdf.."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450716-rebound-pruritus-and-urticaria-post-discontinuation-of-chronic-cetirizine-use-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T23:36:13Z","timestamp":1766878573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450716-rebound-pruritus-and-urticaria-post-discontinuation-of-chronic-cetirizine-use-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.100214","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,27]]}}}